Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals
CA Legare, WM Raup-Konsavage, KE Vrana - Pharmacology, 2022 - karger.com
Background: There is a growing interest in the use of cannabis (and its extracts), as well as
CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is …
CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is …
[HTML][HTML] Cannabinoids: new promising agents in the treatment of neurological diseases
S Giacoppo, G Mandolino, M Galuppo, P Bramanti… - Molecules, 2014 - mdpi.com
Nowadays, Cannabis sativa is considered the most extensively used narcotic. Nevertheless,
this fame obscures its traditional employ in native medicine of South Africa, South America …
this fame obscures its traditional employ in native medicine of South Africa, South America …
Therapeutic potential of cannabinoids in CNS disease
JL Croxford - CNS drugs, 2003 - Springer
The major psychoactive constituent of Cannabis sativa, Δ 9-tetrahydrocannabinol (Δ 9-THC),
and endogenous cannabinoid ligands, such as anandamide, signal through G-protein …
and endogenous cannabinoid ligands, such as anandamide, signal through G-protein …
A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
E Russo, GW Guy - Medical hypotheses, 2006 - Elsevier
This study examines the current knowledge of physiological and clinical effects of
tetrahydrocannabinol (THC) and cannabidiol (CBD) and presents a rationale for their …
tetrahydrocannabinol (THC) and cannabidiol (CBD) and presents a rationale for their …
Cannabinoids for the treatment of neuropathic pain: clinical evidence.
JC Ashton, ED Milligan - Current opinion in investigational drugs …, 2008 - europepmc.org
Neuropathic pain is a worldwide epidemic that occurs in 3 to 8% of individuals in
industrialized countries and is often refractory to existing treatments. Drugs currently …
industrialized countries and is often refractory to existing treatments. Drugs currently …
Medical cannabinoids in children and adolescents: a systematic review
OBJECTIVE: To systematically review published reports to identify the evidence base of
cannabinoids as a medical treatment in children and adolescents. DATA SOURCES: Based …
cannabinoids as a medical treatment in children and adolescents. DATA SOURCES: Based …
Evidence for use of cannabinoids in mood disorders, anxiety disorders, and PTSD: a systematic review
CN Stanciu, MF Brunette, N Teja… - Psychiatric …, 2021 - Am Psychiatric Assoc
Objective: Two primary compounds of the cannabis plant (Cannabis sativa), delta-9-
tetrahydrocannabinol (THC) and cannabidiol (CBD), differentially and dose-dependently …
tetrahydrocannabinol (THC) and cannabidiol (CBD), differentially and dose-dependently …
Use of cannabidiol in anxiety and anxiety-related disorders
JW Skelley, CM Deas, Z Curren, J Ennis - Journal of the American …, 2020 - Elsevier
Objective Cannabidiol (CBD) has a proposed novel role in the management of anxiety
owing to its actions on the endocannabinoid system. The purpose of this systematic review …
owing to its actions on the endocannabinoid system. The purpose of this systematic review …
Systematic review and meta‐analysis of cannabinoids in palliative medicine
M Mücke, M Weier, C Carter, J Copeland… - Journal of cachexia …, 2018 - Wiley Online Library
We provide a systematic review and meta‐analysis on the efficacy, tolerability, and safety of
cannabinoids in palliative medicine. The Cochrane Central Register of Controlled Trials …
cannabinoids in palliative medicine. The Cochrane Central Register of Controlled Trials …
Cannabinoids for symptom management and cancer therapy: the evidence
MP Davis - Journal of the National Comprehensive Cancer …, 2016 - jnccn.org
Cannabinoids bind not only to classical receptors (CB1 and CB2) but also to certain orphan
receptors (GPR55 and GPR119), ion channels (transient receptor potential vanilloid), and …
receptors (GPR55 and GPR119), ion channels (transient receptor potential vanilloid), and …